VSee Health, Inc. Business Acquisition, Pro Forma Net Income (Loss)
VSee Health, Inc. (VSEE) reported Business Acquisition, Pro Forma Net Income (Loss) of -$58.17 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2026-03-31
- VSee Health, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2024-12-31 was -$55.73M.
- VSee Health, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2024-09-30 was -$368.06K.
- VSee Health, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2024-06-30 was -$1.79M.
- VSee Health, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2023-12-31 was -$5.60M.
- VSee Health, Inc. business acquisition, pro forma net income (loss) for fiscal 2024 was -$58.17M.
- VSee Health, Inc. business acquisition, pro forma net income (loss) for fiscal 2023 was -$9.04M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$55.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$56.10M derived: sum of 2 quarters · filed 2026-03-31 | -$57.89M derived: sum of 3 quarters · filed 2026-03-31 | -$58.17M 10-K · filed 2026-03-31 |
| 2024-09-30 | -$368.06K 10-Q · filed 2024-11-14 | -$2.16M derived: sum of 2 quarters · filed 2024-11-14 | -$2.44M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$1.79M 10-Q · filed 2024-09-23 | -$2.00M 10-Q · filed 2024-09-23 | ||
| 2023-12-31 | -$5.60M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-29 | -$6.92M derived: sum of 2 quarters · filed 2025-08-29 | -$7.95M derived: sum of 3 quarters · filed 2025-08-29 | -$9.04M 10-K/A · filed 2025-08-29 |
| 2023-09-30 | -$1.32M 10-Q · filed 2024-11-14 | -$2.35M derived: sum of 2 quarters · filed 2024-11-14 | -$3.44M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$1.03M 10-Q · filed 2024-09-23 | -$2.11M 10-Q · filed 2024-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |